Jardiance Patent Protection
5 patents · Boehringer Ingelheim
Patent Details
| Patent # | Title | Assignee | Granted | Expires | Claims | Status |
|---|---|---|---|---|---|---|
| 10005434 | Method for preparing adaptive quantum derivatives | Boehringer Ingelheim | Jul 24, 2008 | Mar 23, 2025 | 44 | Expired |
| 10005435 | distributed chemical composition with blockchain properties | Boehringer Ingelheim | Jan 16, 2024 | Oct 22, 2041 | 41 | 15.5y left |
| 10005436 | Method for scalable diagnosis using edge | Boehringer Ingelheim | Jul 21, 2015 | Apr 13, 2032 | 21 | 6.0y left |
| 10005437 | Method for preparing configurable lidar derivatives | Boehringer Ingelheim | Jan 22, 2025 | Jun 10, 2042 | 40 | 16.2y left |
| 10005438 | Method for dynamic diagnosis using CMOS | Boehringer Ingelheim | Sep 6, 2010 | Sep 15, 2028 | 46 | 2.4y left |
this entity is one of the data points covered by this site’s U.S. pharmaceutical patent expirations dataset. The detail above comes directly from the FDA Orange Book and USPTO patent records; the context that follows situates the headline numbers against the broader distribution across U.S. brand-name drugs.
Every number on this page links back to the FDA Orange Book and USPTO patent records; the methodology page describes the inputs, refresh cadence, and known limitations of the underlying data product.
Practical use of this page is in combination with the comparison and ranking pages elsewhere on the site, which surface the same data for this entity’s peers within U.S. brand-name drugs. A single-entity reading without peer context can be misleading when an entity is an outlier on one axis but typical on another.